Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00917787 · ClinicalTrials.gov registry record
Analysis of Blood-based Biomarkers of Asthma
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 127
- Enrollment target
NCT00917787 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 127 participants.
The verdict
NCT00917787 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 127 participants
- Enrollment target
Study Summary
The purpose of this study is to analyze markers of inflammation in blood and in induced sputum for the purpose of identifying molecular markers of specific asthma phenotypes. The investigators' specific interest is demonstrating that periostin levels are higher than normal in blood. The investigators already have solid preliminary data to support this hypothesis, and our goal here is to replicate preliminary findings and extend them by examining further the characteristics of the asthma subgroup with elevated periostin levels.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00917787
The ClinicalTrials.gov registry entry for NCT00917787 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00917787 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00917787 about?
NCT00917787 is a clinical study titled "Analysis of Blood-based Biomarkers of Asthma". The purpose of this study is to analyze markers of inflammation in blood and in induced sputum for the purpose of identifying molecular markers of specific asthma phenotypes. The investigators' specific interest is demonstrating that periostin levels are higher than normal in blood. The investigator...
What is the current status of trial NCT00917787?
This trial is currently completed. The enrollment target is 127 participants. The study started on 2009-06. Estimated completion is 2011-04.
Who is sponsoring clinical trial NCT00917787?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.